Key points are not available for this paper at this time.
Following near-absence during the COVID-19 pandemic, Mycoplasma pneumoniae infection has recently reemerged in children, much later than other respiratory pathogens. We describe the resurgence that we have observed starting in late 2023. Compared with prepandemic, disease severity and extrapulmonary manifestations did not change, while median age at presentation increased.
Taborda et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: